News

Filter

Current filters:

Bristol-Myers SquibbUCB

1 to 9 of 25 results

Lupus therapeutics boast blockbuster hopefuls as R&D continues, says GlobalData

24-06-2013

Lupus therapeutics are lacking, and patients with moderate forms of the disease are greatly underserved,…

BenlystaBiotechnologyBristol-Myers SquibbepratuzumabGlaxoSmithKlineImmunologicalsMarkets & MarketingOrenciaPharmaceuticalRare diseasesResearchUCB

Japanese approvals for Novo's Ryzodeg, UCB/Otsuka's Neupro and B-MS/Pfizer's Eliquis

27-12-2012

Danish insulin giant Novo Nordisk (NOVN: NV) revealed on December 15 that the Japanese Ministry of Health,…

Asia-PacificBristol-Myers SquibbCardio-vascularDiabetesEliquisNeuproNeurologicalNovo NordiskOtsukaPfizerPharmaceuticalRegulationRyzodegUCB

Stock Commentary - New York week to Sept 22, 2008

29-09-2008

NEW YORK: equities had another tempestuous week in the reporting period to September 22, which included…

AlpharmaBristol-Myers SquibbUCB

1 to 9 of 25 results

COMPANY SPOTLIGHT

Menarini

Back to top